 | Up a level |
van der Horst, Geertje; van de Merbel, Arjanneke F; Ruigrok, Eline; van der Mark, Maaike H; Ploeg, Emily; Appelman, Laura; Tvingsholm, Siri; Jäätelä, Marja; van Uhm, Janneke; Kruithof-de Julio, Marianna; Thalmann, George N.; Pelger, Rob C M; Bangma, Chris H; Boormans, Joost L; van der Pluijm, Gabri; Zwarthoff, Ellen C (2020). Cationic amphiphilic drugs as potential anticancer therapy for bladder cancer. Molecular oncology, 14(12), pp. 3121-3134. Elsevier 10.1002/1878-0261.12793
La Manna, Federico; De Menna, Marta; Patel, Nikhil; Karkampouna, Sofia; De Filippo, Maria; Klima, Irena; Kloen, Peter; Beimers, Lijkele; Thalmann, George N.; Pelger, Rob C M; Jacinto, Estela; Kruithof-de Julio, Marianna (2020). Dual-mTOR Inhibitor Rapalink-1 Reduces Prostate Cancer Patient-Derived Xenograft Growth and Alters Tumor Heterogeneity. Frontiers in oncology, 10(1012), p. 1012. Frontiers Research Foundation 10.3389/fonc.2020.01012
van den Hoogen, Christel; van der Horst, Geertje; Cheung, Henry; Buijs, Jeroen T; Lippitt, Jenny M; Guzmán-Ramírez, Natalia; Hamdy, Freddie C; Eaton, Colby L; Thalmann, George N; Cecchini, Marco G; Pelger, Rob C M; van der Pluijm, Gabri (2010). High aldehyde dehydrogenase activity identifies tumor-initiating and metastasis-initiating cells in human prostate cancer. Cancer research, 70(12), pp. 5163-73. Birmingham, Ala.: American Association for Cancer Research AACR 10.1158/0008-5472.CAN-09-3806
